Bioretec earns breakthrough designation for spinal interbody cage

Bioretec earned the FDA’s breakthrough device designation for its RemeOs spinal interbody cage, the company said March 14.

Advertisement

RemeOs is designed to restore intervertebral height and facilitate cervical spinal fusion, according to a news release. 

With breakthrough designation Bioretec will look into accelerating development of RemeOs.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.